Navigation Links
Mass. Eye and Ear granted $30,000 medical eye research fellowship

Boston (Jan. 23, 2012) Research to Prevent Blindness (RPB) has awarded Massachusetts Eye and Ear, a teaching affiliate of Harvard Medical School, a $30,000 Medical Student Eye Research Fellowship. The award will support the work of Ms. Mamta Shah.

The award will allow Ms. Shah to participate in research under the mentorship of Mass. Eye and Ear Glaucoma Service Director Dr. Louis Pasquale in collaboration with Dr. Suzanne Freitag, Director of the Mass. Eye and Ear Ophthalmic Plastic Surgery Service. Their study will pursue the development of an algorithm to objectively evaluate anatomical changes in the eye believed to be associated with certain types of eye drops used to treat glaucoma.

"We are grateful to Research to Prevent Blindness for their continued support of eye research at Mass. Eye and Ear. They are one of the important contributors to our effort to find better treatments for patients with debilitating eye conditions," said Dr. Joan W. Miller, Chief of Ophthalmology at Mass. Eye and Ear and Mass General, and Chair of Ophthalmology at Harvard Medical School.


Contact: Vannessa Carrington
Massachusetts Eye and Ear Infirmary

Page: 1

Related medicine news :

1. Mass. General researchers find novel way to prevent drug-induced liver injury
2. Mass. General Cancer Center and Vall dHebron Institute of Oncology biomarker alliance
3. Uninsured patients in Mass. still mainly the working poor, despite states health reform
4. Mass. General team identifies new class of antiangiogenesis drugs
5. Mass. General study reveals how lung cancers evolve in response to targeted treatment
6. Mass. Health Reform Hasnt Halted Medical Bankruptcies
7. Mass. General enters collaboration to develop new approach to capturing circulating tumor cells
8. Mass. doctor invents product to curb hospital-acquired infections
9. Researchers to study effects of Mass. health reform
10. Mass. General Hospital, Iacocca Foundation announce completion of Phase I diabetes trial
11. Mass. Eye and Ear receives NEI grant renewal for growing clinical/scientists
Post Your Comments:
(Date:10/13/2017)... ... ... Journey: From the Mountains to the Mission Field”: the story of a missionary couple ... From the Mountains to the Mission Field” is the creation of published author, Carole ... and currently teaches a class of ladies at her church, which she has taught ...
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... cold therapy products, announced today the introduction of an innovative new design of the ... multipurpose pad so you get maximum comfort while controlling your pain while using cold ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at ...
(Date:9/25/2017)... AMSTERDAM , Sept. 25, 2017   ... Trial Master File solutions, today—from the IQPC Trial ... Amsterdam , NL)—announced that EastHORN Clinical Services ... its clinical programs and TMF management. EastHORN, a ... Montrium,s eTMF platform to increase transparency to enable ...
(Date:9/19/2017)... ANN ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical ... the precise destruction of targeted tissues, announced three leadership team developments today:   ... Josh Stopek, PhD ... ... Veteran medical device executive ...
Breaking Medicine Technology: